Prescription drug · ANDA
medroxyprogesterone acetate NDC 70518-4324
Medroxyprogesterone acetate 150 mg/mL · Injection, Suspension · Intramuscular · REMEDYREPACK INC.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70518-4324-0 | 7051843240070518432400 | 1 SYRINGE, GLASS in 1 CARTON (70518-4324-0) / 1 mL in 1 SYRINGE, GLASSMarketed from Apr 1, 2025 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- medroxyprogesterone acetate
- Generic name (nonproprietary)
- medroxyprogesterone acetate
- Active ingredients
- Medroxyprogesterone acetate — 150 mg/mL
- Dosage form
- Injection, Suspension
- Route
- Intramuscular
- Labeler
- REMEDYREPACK INC.NDC labeler code 70518
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 215397
- Marketing start
- Listing expires
- Other FDA classes
- Progesterone Congeners (Chemical structure)
- Identifiers
- Product ID 70518-4324_5aaae560-10e7-6f49-e063-6294a90af12cSPL ID 5aaae560-10e7-6f49-e063-6294a90af12cSPL set ID a0a92717-c1cb-40eb-a95a-1c5dfd32cfc0RxCUI 1000153UNII C2QI4IOI2G
- Pharmacologic class
- Progestin
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeMed-Code curated
J1050 — Injection, medroxyprogesterone acetate, 1 mg
Billing unit: 1 mg. Units on the claim = dose given ÷ 1 mg.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N470518432400followed by a unit qualifier and the quantityPackage 70518-4324-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Label details couldn’t be retrieved right now. Open the label on DailyMed.
About NDC 70518-4324
- What is NDC 70518-4324?
- 70518-4324 is the product NDC for medroxyprogesterone acetate, Medroxyprogesterone acetate 150 mg/mL injection, suspension, listed with the FDA by REMEDYREPACK INC.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- medroxyprogesterone acetate.
- What is the active ingredient?
- Medroxyprogesterone acetate.
- Who is the labeler?
- REMEDYREPACK INC., NDC labeler code 70518. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for medroxyprogesterone acetate?
- 39 other product NDCs are listed under this name. See all medroxyprogesterone acetate NDCs.
- Is there a related HCPCS / J-code?
- Yes: J1050, Injection, medroxyprogesterone acetate, 1 mg. See Billing references above.
Related NDCs: other medroxyprogesterone acetate products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Medroxyprogesterone Acetate | Medroxyprogesterone acetate 2.5 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4666 | 70518-4666-0070518-4666-02 |
| Medroxyprogesterone Acetate | Medroxyprogesterone acetate 150 mg/mL | Injection, SuspensionIntramuscular | Amneal Pharmaceuticals NY LLC | 60219-1467 | 60219-1467-0160219-1467-02 |
| Medroxyprogesterone Acetate | Medroxyprogesterone acetate 2.5 mg/1 | TabletOral | Coupler LLC | 67046-1480 | 67046-1480-03 |
| Medroxyprogesterone Acetate | Medroxyprogesterone acetate 150 mg/mL | Injection, SuspensionIntramuscular | Xiromed LLC | 70700-315 | 70700-0315-2570700-0315-27 |
| Medroxyprogesterone Acetate | Medroxyprogesterone acetate 10 mg/1 | TabletOral | Northwind Health Company, LLC | 51655-520 | 51655-0520-52 |
| medroxyprogesterone acetate | Medroxyprogesterone acetate 150 mg/mL | Injection, SuspensionIntramuscular | Amneal Pharmaceuticals LLC | 70121-1467 | 70121-1467-0270121-1467-05 |
| medroxyprogesterone acetate | Medroxyprogesterone acetate 150 mg/mL | Injection, SuspensionIntramuscular | Amneal Pharmaceuticals LLC | 70121-1480 | 70121-1480-01 |
| Medroxyprogesterone Acetate | Medroxyprogesterone acetate 150 mg/mL | Injection, SuspensionIntramuscular | Eugia US LLC | 55150-330 | 55150-0330-01 |
| Medroxyprogesterone Acetate | Medroxyprogesterone acetate 150 mg/mL | Injection, SuspensionIntramuscular | Eugia US LLC | 55150-329 | 55150-0329-0155150-0329-25 |
| Medroxyprogesterone Acetate | Medroxyprogesterone acetate 5 mg/1 | TabletOral | Preferred Pharmaceuticals Inc. | 68788-8112 | 68788-8112-0168788-8112-03 |
Other NDCs under ANDA 215397
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| medroxyprogesterone acetate | Medroxyprogesterone acetate 150 mg/mL | Injection, SuspensionIntramuscular | Amneal Pharmaceuticals LLC | 70121-1467 |
| medroxyprogesterone acetate | Medroxyprogesterone acetate 150 mg/mL | Injection, SuspensionIntramuscular | Amneal Pharmaceuticals LLC | 70121-1480 |